Quotes with Resistance & Support
Market Information

Dr Reddys Labs an outperformer, target of Rs 925: Karvy

Posted on: June 11th 2009 in Brokerage Recommendations.

Karvy Stock Broking has recommended an outperformer rating on Dr Reddy’s Labs with a price target of Rs 925 in its report dated June 11, 2009. “Dr Reddys Lab has received the USFDA approval for Omeprazole OTC. Shipment of this product will commence in Q2 FY2010. This is a USD…

Read More..

read more

Breakouts

+ve 30 DMA    50 DMA    150 DMA    200 DMA
-ve 30 DMA    50 DMA    150 DMA    200 DMA

Latest Query

Samrudhiglobal.com wishing you and your friends and family Advance xmas and Happy New year...view more »
- by Sam
Status: Awaiting reply

Market Stats

Search Our Archives

Latest Investment Idea

Recent Comments